| Registered Number | 3236483 |
|---|---|
| Registered Address |
PO Box 244 Upton Road Bristol UK BS99 7UJ |
| Phone Number | +44 (0) 117 9636636 |
| Fax Number | |
| Website | http://www.imperial-tobacco.com |
| Activities | Manufactures and markets cigarettes tobaccos cigars rolling papers and tubes |
| Country of Register | GB |
| Currency | GBX |
| Short Name | IMP.TOBACCO GRP |
| First Day Traded | 17/04/2001 |
| Industrial Sector | Tobacco |
| Number of shares | 1.01b |
| Iain Napier | Chairman |
|---|---|
| Gareth Davis | Chief Executive Officer |
| Michael Herlihy | Non Executive Director |
| Susan Murray | Non Executive Director |
| Pierre Jungels | Non Executive Director |
| Mark Williamson | Non Executive Director |
| Robert Dyrbus | Financial Director |
| Jean-Dominique Comolli | Non Executive Director |
| Berge Setrakian | Non Executive Director |
| Charles Knott | Non Executive Director |
| Graham Blashill | Director |
| Alison Cooper | Director |
| Ken Burnett | Non Executive Director |
| Invesco Asset Management Ltd. | 6.12% |
|---|---|
| BlackRock Investment Management (UK) Ltd. | 5.32% |
| Director | Date | Buy/Sell | Quantity | Price |
|---|---|---|---|---|
You need to be a Selfrade customer to access this data. |
||||
| AR 2007 | AR 2008 | AR 2009 | AR 2010 | AR 2011 | |
| Fiscal Year End | 30/09/2007 | 30/09/2008 | 30/09/2009 | 30/09/2010 | 30/09/2011 |
| Duration (months) | 12 | 12 | 12 | 12 | 12 |
| Accounting Format | IFRS | IFRS | IFRS | IFRS | IFRS |
| Sales/Revenue | 3,280 | 10,116 | 14,748 | 15,018 | 15,186 |
| Cost of Goods Sold (COGS) incl. D&A | 1,017 | 6,549 | 9,900 | 10,031 | 10,156 |
| COGS excluding D&A | 902 | 6,130 | 9,280 | 9,410 | 9,585 |
| Depreciation & Amortization Expense | 115 | 419 | 620 | 621 | 571 |
| Depreciation | 88 | 123 | 152 | 153 | 151 |
| Amortization of Intangibles | 27 | 296 | 468 | 468 | 420 |
| Amortization of Deferred Charges | 0 | 0 | 0 | 0 | 0 |
| Gross Income | 2,263 | 3,567 | 4,848 | 4,987 | 5,030 |
| Selling, General & Administrative Expense | 845 | 1,947 | 2,366 | 2,395 | 2,330 |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Other Selling, General & Administrative | 845 | 1,947 | 2,366 | 2,395 | 2,330 |
| Other Operating Expense | 0 | 0 | 0 | 0 | 0 |
| Non Operating Income/Expense | 88 | 66 | -401 | 55 | 135 |
| Non-Operating Interest Income | 14 | 74 | 39 | 19 | 18 |
| Equity in Affiliates (Pretax) | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| Unusual Expense | 32 | 442 | 436 | -71 | 120 |
| EBIT after Unusual Expense | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 251 | 697 | 739 | 619 | 580 |
| Gross Interest Expense | 251 | 697 | 739 | 619 | 580 |
| Interest Capitalized | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | 1,237 | 621 | 945 | 2,118 | 2,153 |
| Income Tax | 325 | 180 | 268 | 596 | 337 |
| Income Tax - Current Domestic | 120 | 2 | 61 | -37 | -29 |
| Income Tax - Current Foreign | 172 | 359 | 346 | 534 | 350 |
| Income Tax - Deferred Domestic | 33 | -181 | -139 | 99 | 16 |
| Income Tax - Deferred Foreign | 0 | 0 | 0 | 0 | 0 |
| Income Tax Credits | 0 | 0 | 0 | 0 | 0 |
| Minority Interest Expense | 7 | 13 | 14 | 17 | 20 |
| Equity in Affiliates | 0 | 0 | 0 | 0 | 0 |
| Other After Tax Income (Expense) | 0 | 0 | 0 | 0 | 0 |
| Net Income | 905 | 428 | 663 | 1,505 | 1,796 |
| Extraordinaries & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Extra Items & Gain/Loss Sale Of Assets | 0 | 0 | 0 | 0 | 0 |
| Cumulative Effect - Accounting Chg | 0 | 0 | 0 | 0 | 0 |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
| Net Income After Extraordinaries | 905 | 428 | 663 | 1,505 | 1,796 |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
| Net Income available to Common | 905 | 428 | 663 | 1,505 | 1,796 |
| Operational EPS | 118.81 | 86.80 | 95.39 | 143.11 | 185.04 |
| EPS (basic) | 116.43 | 50.60 | 65.50 | 148.50 | 177.30 |
| EPS (diluted) | 115.94 | 50.38 | 65.32 | 148.00 | 176.77 |
| EBITDA | 1,533 | 2,039 | 3,102 | 3,213 | 3,271 |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| +Depreciation & Amortization Expense | 115 | 419 | 620 | 621 | 571 |